Mumbai: Sharekhan has launched SpeedTrade-an Internet-enabled
client server application providing customers with real-time
trading experience.
It is a complete
trading system on the web which not only replicates features
of an exchange terminal in all aspects including speed,
but also provides additional information relevant to day-traders.
While existing
web trading systems require users to continuously refresh
the web page on the browser to receive the latest update,
SpeedTrade streams all information to the trader over
the web.
`P1+''
reaffirmed for Cipla, Pfizer CPs
Mumbai: Credit Rating Information Services of India
Ltd (Crisil) has reaffirmed its `P1+'' rating, (indicating
highest safety) assigned to the Rs 15-crore commercial
paper programme of Cipla Ltd and the Rs 30-crore commercial
paper programme of Pfizer Ltd.
According to a
press release, the ratings reflect the two company''s strong
position as leading players in the Rs 15,600-crore domestic
pharmaceutical industry.
The rating for
Cipla factors in the sales growth arising from successful
new product launches as well as profitability margins
that the company enjoys on account of process re-engineering
capabilities and value-added specialty exports to developed
markets.
Cipla has a presence
in the anti-asthma, anti-infective, anti-AIDS and cardiovascular
segments and a moderate presence in the anti-inflammatory
and anti-ulcerants segments.
The rating for
Pfizer reflects the strong business position complemented
by a favourable financial risk profile characterised by
healthy profitability and zero-debt. In addition to pharmaceuticals,
which accounted for 82 per cent in Pfizer''s turnover in
2001, the company also operates in the animal health industry
(15 per cent of turnover in 2001).
.
.
|